Nuclear protein phosphorylation and hormone-dependent mammary tumor regression following dibutyryl cyclic adenosine 3':5'-monophosphate treatment or ovariectomy.
D015127:9,10-Dimethyl-1,2-benzanthracene; D000818:Animals; D003994:Bucladesine / Q000627:therapeutic use*; D002369:Castration; D005260:Female; D006657:Histones / Q000378:metabolism; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced / Q000378:metabolism / Q000628:therapy*; D009363:Neoplasm Proteins / Q000378:metabolism*; D009376:Neoplasms, Hormone-Dependent / Q000139:chemically induced / Q000378:metabolism / Q000628:therapy*; D009698:Nucleoproteins / Q000378:metabolism*; D010766:Phosphorylation; D011494:Protein Kinases / Q000378:metabolism; D051381:Rats; D012075:Remission, Spontaneous
D006657:Histones; D009363:Neoplasm Proteins; D009698:Nucleoproteins; D015127:9,10-Dimethyl-1,2-benzanthracene; D003994:Bucladesine; D011494:Protein Kinases